The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems, and in particular connectors for stimulation leads and methods of making and using the connectors.
Implantable electrical stimulation systems have proven therapeutic in a variety of diseases and disorders. For example, spinal cord stimulation systems have been used as a therapeutic modality for the treatment of chronic pain syndromes. Peripheral nerve stimulation has been used to treat chronic pain syndrome and incontinence, with a number of other applications under investigation. Functional electrical stimulation systems have been applied to restore some functionality to paralyzed extremities in spinal cord injury patients.
Stimulators have been developed to provide therapy for a variety of treatments. A stimulator can include a control module (with a pulse generator), at least one lead, and an array of stimulator electrodes on each lead. The stimulator electrodes are in contact with or near the nerves, muscles, or other tissue to be stimulated. The pulse generator in the control module generates electrical pulses that are delivered by the electrodes to body tissue.
One embodiment is a connector that includes an electrical stimulation lead connector that includes a connector housing. The connector housing defines a lead lumen having a width, a lead receiving opening, an end stop, a midpoint between the lead receiving opening and the end stop, and a longitudinal length extending from the lead receiving opening to the end stop. The width of the lead lumen decreases from the lead receiving opening to the midpoint and from the midpoint to the end stop. The electrical stimulation lead connector also includes a plurality of contacts disposed in the connector housing and longitudinally spaced apart from each other along the longitudinal length of the lead lumen. Each of the contacts is configured and arranged to electrically couple to a corresponding terminal of a lead body when an end portion of the lead body is inserted into the lead lumen.
In at least some embodiments, the width of the lead lumen decreases monotonically from the lead receiving opening to the midpoint and from the midpoint to the end stop. In at least some embodiments, the lead lumen has an outer surface with a slope having a grade of at least 0.5%. In at least some embodiments, the width of the lead lumen continuously tapers along the longitudinal length of the lead lumen from the lead receiving opening to the end stop. In at least some embodiments, the width of the lead lumen decreases uniformly along the longitudinal length of the lead lumen from the lead receiving opening to the end stop.
In at least some embodiments, the width of the lead lumen decreases in discrete steps along the longitudinal length of the lead lumen from the lead receiving opening to the end stop. In at least some embodiments, the width of the lead lumen decreases incrementally along the longitudinal length of the lead lumen from the lead receiving opening to the end stop.
In at least some embodiments, each of the contacts defines a portion of the lead lumen. In at least some embodiments, each of the contacts has an inner diameter that is different than an inner diameter of at least another one of the contacts. In at least some embodiments, at least one of the contacts has an inner diameter that tapers from a larger inner diameter at one end of the at least one contact to smaller inner diameter at another end of the at least one contact. In at least some embodiments, a first one of the contacts has an inner diameter that exceeds an inner diameter of a second one of the contacts, where the first one of the contacts is nearer the lead receiving opening than the second one of the contacts. In at least some embodiments, the contact nearest the end stop has an inner diameter that is smaller than an inner diameter of each of the other contacts.
Another embodiment is an electrical stimulation lead connector system that includes any of the electrical stimulation lead connectors described above and an electrical stimulation lead. The electrical stimulation lead includes a lead body comprising a longitudinal surface, a distal end portion, a proximal end portion, a proximal tip, and a longitudinal length. The proximal end portion is configured and arranged for insertion into the electrical stimulation lead connector and has a non-uniform width that increases from the proximal tip. The electrical stimulation lead also includes a plurality of terminals disposed along the proximal end portion of the lead body. Each of the terminals is configured and arranged to electrically couple to a corresponding one of the contacts of the electrical stimulation lead connector when the proximal end portion of the lead body is inserted into the lead lumen of the connector housing of the electrical stimulation lead connector. The electrical stimulation lead additionally includes a plurality of electrodes disposed along the distal end portion of the lead body. The electrical stimulation lead further includes a plurality of conductors electrically coupling the terminals to the electrodes.
In at least some embodiments, the width of the proximal end portion of the lead body has a grade of at least 0.5%. In at least some embodiments, the width of the proximal end portion of the lead body continuously tapers toward the proximal tip. In at least some embodiments, the width of the proximal end portion of the lead body increases uniformly from the proximal tip. In at least some embodiments, each of the terminals that is distal to a most proximal one of the terminals has a width that exceeds a width of the most proximal one of the terminals.
A further embodiment is an electrical stimulation lead that includes a lead body. The lead body includes a longitudinal surface, a distal end portion, a proximal end portion, a proximal tip, and a longitudinal length. The proximal end portion is configured and arranged for insertion into an electrical stimulation lead connector and has a non-uniform width that increases from the proximal tip. The lead also includes a plurality of terminals disposed along the proximal end portion of the lead body. Each of the terminals is configured and arranged to electrically couple to a corresponding one of a plurality of contacts of the electrical stimulation lead connector when the proximal end portion of the lead body is inserted into a lead lumen of a connector housing of the electrical stimulation lead connector. The lead additionally includes a plurality of electrodes disposed along the distal end portion of the lead body. The lead further includes a plurality of conductors electrically coupling the terminals to the electrodes.
In at least some embodiments, the width of the proximal end portion of the lead body has a grade of at least 0.5%. In at least some embodiments, the width of the proximal end portion of the lead body continuously tapers toward the proximal tip. In at least some embodiments, the width of the proximal end portion of the lead body increases uniformly from the proximal tip.
Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.
For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:
The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems, and in particular connectors for latching stimulation leads and methods of making and using the connectors.
Suitable implantable electrical stimulation systems include, but are not limited to, a least one lead with at least one electrode disposed along a distal end of the lead and at least one terminal disposed along the at least one proximal end of the lead. Leads include, for example, percutaneous leads, paddle leads, and cuff leads. Examples of electrical stimulation systems with leads are found in, for example, U.S. Pat. Nos. 6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,244,150; 7,450,997; 7,672,734; 7,761,165; 7,783,359; 7,792,590; 7,809,446; 7,949,395; 7,974,706; 8,175,710; 8,224,450; 8,271,094; 8,295,944; 8,364,278; 8,391,985; and 8,688,235; and U.S. Patent Applications Publication Nos. 2007/0150036; 2009/0187222; 2009/0276021; 2010/0076535; 2010/0268298; 2011/0005069; 2011/0004267; 2011/0078900; 2011/0130817; 2011/0130818; 2011/0238129; 2011/0313500; 2012/0016378; 2012/0046710; 2012/0071949; 2012/0165911; 2012/0197375; 2012/0203316; 2012/0203320; 2012/0203321; 2012/0316615; 2013/0105071; and 2013/0197602, all of which are incorporated by reference.
It will be understood that the electrical stimulation system can include more, fewer, or different components and can have a variety of different configurations including those configurations disclosed in the electrical stimulation system references cited herein. For example, instead of a paddle body, the electrodes can be disposed in an array at or near the distal end of a lead body forming a percutaneous lead.
The lead 103 can be coupled to the control module 102 in any suitable manner. In
In
With reference to
The electrical stimulation system 100 or components of the electrical stimulation system 100, including the paddle body 104, the at least one of the lead bodies 106, and the control module 102, are typically implanted into the body of a patient. The electrical stimulation system 100 can be used for a variety of applications including, but not limited to deep brain stimulation, neural stimulation, spinal cord stimulation, muscle stimulation, and the like.
The electrodes 134 can be formed using any conductive, biocompatible material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, at least one of the electrodes 134 are formed from at least one of: platinum, platinum iridium, palladium, palladium rhodium, or titanium.
Any suitable number of electrodes 134 can be disposed on the lead 103 including, for example, one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, fourteen, sixteen, twenty-four, thirty-two, or more electrodes 134. In the case of paddle leads, the electrodes 134 can be disposed on the paddle body 104 in any suitable arrangement. In
The electrodes 134 of the paddle body 104 (or at least one lead body 106) are typically disposed in, or separated by, a non-conductive, biocompatible material such as, for example, silicone, polyurethane, polyetheretherketone (“PEEK”), epoxy, and the like or combinations thereof. The at least one lead body 106 and, if applicable, the paddle body 104 may be formed in the desired shape by any process including, for example, molding (including injection molding), casting, and the like. The non-conductive material typically extends from the distal ends of the at least one lead body 106 to the proximal end of each of the at least one lead body 106.
In the case of paddle leads, the non-conductive material typically extends from the paddle body 104 to the proximal end of each of the at least one lead body 106. Additionally, the non-conductive, biocompatible material of the paddle body 104 and the at least one lead body 106 may be the same or different. Moreover, the paddle body 104 and the at least one lead body 106 may be a unitary structure or can be formed as two separate structures that are permanently or detachably coupled together.
Terminals (for example, 310 in
The control module connector 144 defines at least one port into which a proximal end of the elongated device 300 can be inserted, as shown by directional arrows 312a and 312b. In
The control module connector 144 also includes a plurality of connector contacts, such as connector contact 314, disposed within the lead lumen associated with each port 304a and 304b. When the elongated device 300 is inserted into the ports 304a and 304b, the connector contacts 314 can be aligned with a plurality of terminals 310 disposed along the proximal end(s) of the elongated device(s) 300 to electrically couple the control module 102 to the electrodes (134 of
A lead extension connector 322 is disposed on the lead extension 324. In
In at least some embodiments, the proximal end of the lead extension 324 is similarly configured as a proximal end of the lead 103 (or other elongated device 300). The lead extension 324 may include a plurality of electrically conductive wires (not shown) that electrically couple the connector contacts 340 to a proximal end 348 of the lead extension 324 that is opposite to the distal end 326. In at least some embodiments, the conductive wires disposed in the lead extension 324 can be electrically coupled to a plurality of terminals (not shown) disposed along the proximal end 348 of the lead extension 324. In at least some embodiments, the proximal end 348 of the lead extension 324 is configured for insertion into a connector disposed in another lead extension (or another intermediate device). In other embodiments (and as shown in
The terms “proximal” and “distal” are used consistently with respect to all elements of the lead and system and are defined relative to the proximal end portion of the lead which attaches to the control module. The distal end portion of the lead has the electrodes disposed thereon.
When the lead 400 includes both ring electrodes 420 and segmented electrodes 450, the ring electrodes 420 and the segmented electrodes 450 may be arranged in any suitable configuration. For example, when the lead 400 includes ring electrodes 420 and segmented electrodes 450, the ring electrodes 420 can flank some or all of the segmented electrodes 450 (see, for example,
By varying the selection of the segmented electrodes 450, different coverage of the target neurons may be selected. For example, the electrode arrangement of
Any combination of ring electrodes 420 and segmented electrodes 450 may be disposed on the lead 400. For example, the lead may include a first ring electrode 420, two sets of segmented electrodes 450; each set formed of four segmented electrodes 450, and a final ring electrode 420 at the end of the lead (not shown). This configuration may simply be referred to as a 1-4-4-1 configuration. It may be useful to refer to the electrodes with this shorthand notation. Thus, the embodiment of
Other electrode configurations include, for example, a 1-3-3-1 configuration (where two sets of segmented electrodes, each having three segmented electrodes, are disposed on the lead), a 1-1-4-4 configuration (where two sets of segmented electrodes, each having four segmented electrodes, are disposed on the lead), a 4-4-1-1 configuration (where two sets of segmented electrodes, each having four segmented electrodes, are disposed on the lead), a 2-2-2-2 configuration (where four sets of segmented electrodes are disposed on the lead), and a 4-4 configuration (where two sets of segmented electrodes, each having four segmented electrodes 550 are disposed on the lead). In some embodiments, the lead includes 16 electrodes. Possible configurations for a 16-electrode lead include, but are not limited to, 4-4-4-4; 1-1-6-8; 5-3-3-3-3-1 (and all rearrangements of this configuration); and 2-2-2-2-2-2-2-2. Any other suitable segmented electrode arrangements (with or without ring electrodes) can be used including, but not limited to, those disclosed in U.S. Provisional Patent Application Ser. No. 62/113,291 and U.S. Patent Applications Publication Nos. 2012/0197375 and 2015/0045864, all of which are incorporated herein by reference in their entirety. In at least some embodiments, a lead includes a terminal for each electrode on the lead (for example, a lead with 16 electrodes may include 16 terminals).
The amount of force to insert the proximal end of a lead into a connector or to remove the proximal end of the lead from the connector (or duration or quantity of application of that force) typically increases with each additional terminal on the lead. For example, each contact (or other component in the connector) that a terminal passes during insertion into or removal from the connector can interfere with insertion or removal. In this example, when multiple contacts (or other components in the connector) interfere with multiple terminals at once, the amount of force applied to progressively insert or remove the lead can increase. Also in this example, as the number of interfering contacts (or other components in the connector) that a terminal must pass increases, the duration or quantity of application of force applied to insert or remove the lead can increase. Although a segmented electrode lead (e.g., a directional lead) is used as an example herein, these considerations, as well as the arrangements and structure described below, can apply to any type of lead including, but not limited to, paddle leads (see, for example,
Consequently, a lead that includes a large number of terminals along a single tail of the lead may prove difficult for a physician to insert into or remove from a connector (at least in comparison to a lead that includes fewer terminals). To mitigate this issue, a lead that includes 16 terminals may have the tail split into two tails, each having 8 terminals (see, for example,
Although some of the embodiments described below are presented as connectors of control modules, it will be understood that the arrangements described below can also be applied to other connectors, such as connectors for lead extensions (seem for example,
Also, although some of the embodiments described below are presented as connectors to receive the proximal end of leads, it will be understood that the arrangements described below can also be applied to a connector that receives any end of a lead extension or other elongate member having terminals, contacts, or the like. In general, any elongate member can have first contacts (for example, electrodes for a lead or conductive contacts for a lead extension) disposed along a distal portion of the elongate member and second contacts (for example, segmented terminals) disposed along a proximal portion of the elongate member.
The lead lumen has a distal width 528 at the lead receiving opening 520 of the lead lumen 518. The connector elements that define the lead lumen 518 may have different radial thicknesses 526 or inner diameters 524 along the longitudinal length of the lead lumen 518. For example, the radial thicknesses can range from a distal radial thickness 526 for the distal-most connector element down to a proximal radial thickness 530 for the proximal-most connector element.
The lead lumen 518 has a width that varies along the longitudinal length of the lead lumen 518. For example, in the embodiments illustrated in
The outer diameter 525 or radial thickness 526 of the contact elements may be uniform or vary along the length of the connector. For example, in the embodiment illustrated in
In the embodiment illustrated in
In at least some embodiments, the lead lumen 518 has an end stop 522, with a proximal width 532, and a lead receiving opening 520, with a distal width 528 that exceeds the proximal width 532. In at least some embodiments, the varying width of the lead lumen 518 facilitates inserting a greater portion of the insertion portion 550 of the lead body 506 into the lead lumen 518 prior to encountering substantial resistance to insertion (at least in comparison to a lead lumen and an insertion portion that have constant widths). In at least some embodiments, the distal width 528 of the lead lumen 518 is at least 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 100% greater than the proximal width 532 of the lead lumen 518.
In at least some embodiments, at least one connector element has an inner diameter 524 that exceeds the inner diameter of the adjacent connector element that is distal to the at least one connector element. For example, every other connector element along the longitudinal length of the lead lumen 518 may be a spacer 508 that separates two connector contacts 514. In this example, the inner diameter of the spacer 508 may be greater than the inner diameter of the one of the connector contacts 514 that the spacer 508 separates and less than the inner diameter of the other of the connector contacts. Also in this example, the distal-most connector contact 514 of a pair of connector contacts 514 has an inner diameter that exceeds the inner diameter of the proximal-most connector contact 514 of the pair of connector contacts 514. In at least some embodiments, the inner diameter of a connector element is defined as the smallest inner diameter of that connector element.
The connector elements can be disposed in the connector in any suitable manner including, for example, an interference fit, adhesive, welding, soldering, or the like. The connector contacts 514 can be formed from any electrically-conductive material suitable for implantation including, for example, one or more shape-memory materials, MP35N, stainless steel, or the like. In at least some embodiments, a connector contact 514 includes a contact housing and at least one contact contained in the contact housing. In at least some embodiments, the contact housing and the at least one contact are both formed from electrically-conductive materials and can be electrically coupled to each other. In at least some embodiments, each connector element can be a single-piece assembly. For example, a contact housing and a connector contact 514 or a spacer 508 contained in the contact housing can be collectively formed from the same, single piece of material.
In at least some embodiments, the spacers 508 can facilitate correctly spacing the contacts 514 to align with terminals on an inserted lead body. In at least some embodiments, the spacers 508 can also perform as or include seals. In at least some embodiments, the spacers 508 are made of non-conductive, biocompatible material suitable for implantation.
In at least some embodiments, the outer cross-sectional shape of the connector elements is circular, substantially circular, polygonal, substantially polygonal, or the like while defining a tubular passage through the connector element that forms a portion of the lead lumen 518. In at least some embodiments, the lead lumen 518 may form any circumferential shape suitable for receiving a proximal end portion of a lead body. In at least some embodiments, the cross-sectional shape of the lead lumen 518 is circular, substantially circular, polygonal, substantially polygonal, or the like. For example, the lead lumen 518 and corresponding lead can have a polygonal cross-sectional shape, such as a rectangular, hexagonal, or octagonal cross-sectional shape. In such instances, the width 528 corresponds to a distance between two opposing sides of the rectangular, hexagonal, octagonal, or other polygonal cross-sectional shape. For these cross-sectional shapes, two or more widths 528 are defined for a lead lumen 518 and corresponding lead 506 and, in some instances, for example, for some rectangular cross-sectional shapes, the two or more widths 528 differ in size. In some embodiments, the lead lumen 518 and corresponding lead 506 may decrease along only one of those widths. In other embodiments, the lead lumen 518 and corresponding lead 506 may decrease along two or more (or all) of those widths. The connector contacts 514 and spacers 508 are described herein as being cylindrical, but it will be understood that they can also have a substantially circular, polygonal, or substantially polygonal cross-sectional shape. For such cross-sectional shapes, the inner and outer dimensions of the connector contacts 514 and spacers 508 may vary in the same manner as described above for the inner diameter 524 and outer diameter 525 of the connector contacts 514 or the width 528 of the lead lumen 518.
In at least some embodiments, the connector elements that define the lead lumen 518 include at least one, two, three, four, six, eight, ten, 12, 14, or 16 connector contacts 514; zero, one, two, three, four, six, eight, ten, 12, 14, 16, or more spacers 508; and zero, one, or more retention blocks 534. In at least some embodiments, the connector contacts 514 each have the same or different longitudinal length as other connector contacts 514. In at least some embodiments, the spacers 508 each have the same or different longitudinal length as other spacers 508. In at least some embodiments, the retention block 534 has the same or different longitudinal length as at least one connector contact 514. In at least some embodiments, the number of spacers is equal to, or one more than, the number of connector contacts. In at least some embodiments, the number of spacers is equal to, or one more than, the combined number of connector contacts and retention blocks.
In at least some embodiments, some of the connector elements are resilient or include resilient portions. Examples of resilient connector elements can include resilient contacts, coiled springs, leaf springs, seals, or the like that form at least part of a connector contact 514. In at least some embodiments, the inner diameter (or the radial thickness) of a resilient connector element can be defined as the inner diameter (or the radial thickness) either a) when the resilient connector element is compressed (for example, when the lead body 506 of
Any suitable type of connector contact can be used including, but not limited to, those described in U.S. Pat. Nos. 6,741,892; 7,244,150; and 8,682,439; U.S. Patent Application Publications Nos. 2008/0071320; 2011/0022100; and 2016/0059019; and U.S. Patent Application Ser. No. 62/193,472, all of which are incorporated herein by reference. In at least some embodiments, at least one of the connector contacts 514 may include a connector-contact assembly. In at least some embodiments, connector-contact assemblies include contact housings that contain at least one portion of one or more resilient members. In at least some embodiments, a contact housing forms a cylindrical shape, having an outer surface about the exterior portion of the cylindrical shape and an inner surface that defines a portion of the lead lumen 518 that extends through the cylindrical shape.
The insertion portion 550 of the lead body 506 includes a plurality of terminals 510 or other contacts. In at least some embodiments, at least one terminal forms at least one portion of a ring that has a constant width along the longitudinal length of the terminal. In at least some embodiments, at least one terminal forms at least one portion of a ring that has a larger width at the distal end portion of the terminal and a smaller width at the proximal end portion of the terminal. In at least some embodiments, at least one terminal has a width that exceeds a width of the next-most proximal terminal. In at least some embodiments, when the insertion portion 550 is inserted into the lead lumen 518, each terminal aligns with and electrically couples to a corresponding contact in the lead lumen 518. In at least some embodiments, the plurality of terminals 510 includes two, three, four, five, six, seven, eight, nine, ten, 11, 12, 13, 14, 15, or 16 or more terminals.
In at least some embodiments, the insertion portion 550 includes at least one retention sleeve 548. In at least some embodiments, when the insertion portion 550 is inserted into the lead lumen 518, the retention block 534 can be used to facilitate retention of the lead body 506. For example, the retention sleeve 548 may enable applying a fastener (for example, a set screw, pin, or the like) to the retention sleeve 548 through the retention block 534. In at least some embodiments, the retention sleeve 548 can also be a terminal and the retention block 534 can also be a connector contact.
Some of the components (for example, a power source 612, an antenna 618, a receiver 602, and a processor 604) of the electrical stimulation system can be positioned on at least one circuit board or similar carrier within a sealed housing of an implantable pulse generator, if desired. Any power source 612 can be used including, for example, a battery such as a primary battery or a rechargeable battery. Examples of other power sources include super capacitors, nuclear or atomic batteries, mechanical resonators, infrared collectors, thermally-powered energy sources, flexural powered energy sources, bioenergy power sources, fuel cells, bioelectric cells, osmotic pressure pumps, and the like including the power sources described in U.S. Pat. No. 7,437,193, incorporated herein by reference.
As another alternative, or in addition, power can be supplied by an external power source through inductive coupling via the optional antenna 618 or a secondary antenna. The external power source can be in a device that is mounted on the skin of the user or in a unit that is provided near the user on a permanent or periodic basis.
If the power source 612 is a rechargeable battery, the battery may be recharged using the optional antenna 618, if desired. Power can be provided to the battery for recharging by inductively coupling the battery through the antenna to a recharging unit 916 external to the user. Examples of such arrangements can be found in the references identified above.
In one embodiment, electrical current is emitted by the electrodes 134 on the paddle or lead body to stimulate nerve fibers, muscle fibers, or other body tissues near the electrical stimulation system. The processor 604 is generally included to control the timing and electrical characteristics of the electrical stimulation system. For example, the processor 604 can, if desired, control at least one of the timing, frequency, strength, duration, and waveform of the pulses. In addition, the processor 604 can select which electrodes can be used to provide stimulation, if desired. In at least some embodiments, the processor 604 selects which electrode(s) are cathodes and which electrode(s) are anodes. In at least some embodiments, the processor 604 is used to identify which electrodes provide the most useful stimulation of the desired tissue.
Any processor can be used and can be as simple as an electronic device that, for example, produces pulses at a regular interval or the processor can be capable of receiving and interpreting instructions from an external programming unit 608 that, for example, allows modification of pulse characteristics. In the illustrated embodiment, the processor 604 is coupled to a receiver 602 which, in turn, is coupled to the optional antenna 618. This allows the processor 604 to receive instructions from an external source to, for example, direct the pulse characteristics and the selection of electrodes, if desired.
In one embodiment, the antenna 618 is capable of receiving signals (for example, RF signals) from an external telemetry unit 606 which is programmed by the programming unit 608. The programming unit 608 can be external to, or part of, the telemetry unit 606. The telemetry unit 606 can be a device that is worn on the skin of the user or can be carried by the user and can have a form similar to a pager, cellular phone, or remote control, if desired. As another alternative, the telemetry unit 606 may not be worn or carried by the user but may only be available at a home station or at a clinician's office. The programming unit 608 can be any unit that can provide information to the telemetry unit 606 for transmission to the electrical stimulation system 600. The programming unit 608 can be part of the telemetry unit 606 or can provide signals or information to the telemetry unit 606 via a wireless or wired connection. One example of a suitable programming unit is a computer operated by the user or clinician to send signals to the telemetry unit 606.
The signals sent to the processor 604 via the antenna 618 and the receiver 602 can be used to modify or otherwise direct the operation of the electrical stimulation system. For example, the signals may be used to modify the pulses of the electrical stimulation system such as modifying at least one of pulse duration, pulse frequency, pulse waveform, and pulse strength. The signals may also direct the electrical stimulation system 600 to cease operation, to start operation, to start charging the battery, or to stop charging the battery. In other embodiments, the stimulation system does not include the antenna 618 or receiver 602 and the processor 604 operates as programmed.
Optionally, the electrical stimulation system 600 may include a transmitter (not shown) coupled to the processor 604 and the antenna 618 for transmitting signals back to the telemetry unit 606 or another unit capable of receiving the signals. For example, the electrical stimulation system 600 may transmit signals indicating whether the electrical stimulation system 600 is operating properly or not or indicating when the battery needs to be charged or the level of charge remaining in the battery. The processor 604 may also be capable of transmitting information about the pulse characteristics so that a user or clinician can determine or verify the characteristics.
The above specification provides a description of the invention and the manufacture and use of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.
This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/483,141, filed Apr. 7, 2017, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3222471 | Steinkamp | Dec 1965 | A |
3601747 | Prall et al. | Aug 1971 | A |
3718142 | Mulier | Feb 1973 | A |
3757789 | Shanker | Sep 1973 | A |
3771106 | Matsumoto et al. | Nov 1973 | A |
3908668 | Bolduc | Sep 1975 | A |
3951154 | Hartlaub | Apr 1976 | A |
3990727 | Gallagher | Nov 1976 | A |
4003616 | Springer | Jan 1977 | A |
4112953 | Shanker et al. | Sep 1978 | A |
4142532 | Ware | Mar 1979 | A |
4180078 | Anderson | Dec 1979 | A |
4245642 | Skubitz et al. | Jan 1981 | A |
4259962 | Peers-Trevarton | Apr 1981 | A |
4310001 | Comben | Jan 1982 | A |
4364625 | Baker et al. | Dec 1982 | A |
4367907 | Buck | Jan 1983 | A |
4411276 | Dickhudt et al. | Oct 1983 | A |
4411277 | Dickhudt | Oct 1983 | A |
4461194 | Moore | Jul 1984 | A |
4466441 | Skubitz et al. | Aug 1984 | A |
4516820 | Kuzma | May 1985 | A |
RE31990 | Sluetz et al. | Sep 1985 | E |
4540236 | Peers-Trevarton | Sep 1985 | A |
4602624 | Naples et al. | Jul 1986 | A |
4603696 | Cross, Jr. et al. | Aug 1986 | A |
4614395 | Peers-Trevarton | Sep 1986 | A |
4630611 | King | Dec 1986 | A |
4695116 | Bailey et al. | Sep 1987 | A |
4695117 | Kysiak | Sep 1987 | A |
4712557 | Harris | Dec 1987 | A |
4715380 | Harris | Dec 1987 | A |
4744370 | Harris | May 1988 | A |
4784141 | Peers-Trevarton | Nov 1988 | A |
4832032 | Schneider | May 1989 | A |
4840580 | Saell et al. | Jun 1989 | A |
4850359 | Putz | Jul 1989 | A |
4860750 | Frey et al. | Aug 1989 | A |
4867708 | Iizuka | Sep 1989 | A |
4869255 | Putz | Sep 1989 | A |
4898173 | Daglow et al. | Feb 1990 | A |
4899753 | Inoue et al. | Feb 1990 | A |
4951687 | Ufford et al. | Aug 1990 | A |
4995389 | Harris | Feb 1991 | A |
5000177 | Hoffman et al. | Mar 1991 | A |
5000194 | van den Honert et al. | Mar 1991 | A |
5007435 | Doan et al. | Apr 1991 | A |
5007864 | Stutz, Jr. | Apr 1991 | A |
5070605 | Daglow et al. | Dec 1991 | A |
5082453 | Stutz, Jr. | Jan 1992 | A |
5086773 | Ware | Feb 1992 | A |
5135001 | Sinofsky et al. | Aug 1992 | A |
5193539 | Schulman et al. | Mar 1993 | A |
5193540 | Schulman et al. | Mar 1993 | A |
5201865 | Kuehn | Apr 1993 | A |
5241957 | Camps et al. | Sep 1993 | A |
5252090 | Giurtino et al. | Oct 1993 | A |
5261395 | Oleen et al. | Nov 1993 | A |
5312439 | Loeb | May 1994 | A |
5324312 | Stokes et al. | Jun 1994 | A |
5330521 | Cohen | Jul 1994 | A |
5336246 | Dantanarayana | Aug 1994 | A |
5348481 | Ortiz | Sep 1994 | A |
5354326 | Comben et al. | Oct 1994 | A |
5358514 | Schulman et al. | Oct 1994 | A |
5368496 | Ranalletta et al. | Nov 1994 | A |
5374279 | Duffin, Jr. et al. | Dec 1994 | A |
5374285 | Vaiani et al. | Dec 1994 | A |
5383913 | Schiff | Jan 1995 | A |
5413595 | Stutz, Jr. | May 1995 | A |
5433734 | Stokes et al. | Jul 1995 | A |
5435731 | Kang | Jul 1995 | A |
5458629 | Baudino et al. | Oct 1995 | A |
5486202 | Bradshaw | Jan 1996 | A |
5489225 | Julian | Feb 1996 | A |
5509928 | Acken | Apr 1996 | A |
5522874 | Gates | Jun 1996 | A |
5534019 | Paspa | Jul 1996 | A |
5545188 | Bradshaw et al. | Aug 1996 | A |
5545189 | Fayram | Aug 1996 | A |
5582180 | Manset et al. | Aug 1996 | A |
5560358 | Arnold et al. | Oct 1996 | A |
5679026 | Fain et al. | Oct 1997 | A |
5683433 | Carson | Nov 1997 | A |
5711316 | Elsberry et al. | Jan 1998 | A |
5713922 | King | Feb 1998 | A |
5720631 | Carson et al. | Feb 1998 | A |
5730628 | Hawkins | Mar 1998 | A |
5755743 | Volz et al. | May 1998 | A |
5766042 | Ries et al. | Jun 1998 | A |
5782892 | Castle et al. | Jul 1998 | A |
5796044 | Cobian et al. | Aug 1998 | A |
5800350 | Coppleson et al. | Sep 1998 | A |
5800495 | Machek et al. | Sep 1998 | A |
5807144 | Sivard | Sep 1998 | A |
5837006 | Ocel et al. | Nov 1998 | A |
5843141 | Bischoff et al. | Dec 1998 | A |
5843148 | Gijsbers et al. | Dec 1998 | A |
5906634 | Flynn et al. | May 1999 | A |
5931861 | Werner et al. | Aug 1999 | A |
5938688 | Schiff | Aug 1999 | A |
5951595 | Moberg et al. | Sep 1999 | A |
5968082 | Heil | Oct 1999 | A |
5987361 | Mortimer | Nov 1999 | A |
5989077 | Mast et al. | Nov 1999 | A |
6006135 | Kast et al. | Dec 1999 | A |
6018684 | Bartig et al. | Jan 2000 | A |
6038479 | Werner et al. | Mar 2000 | A |
6038481 | Werner et al. | Mar 2000 | A |
6042432 | Hashizawa et al. | Mar 2000 | A |
6051017 | Loeb et al. | Apr 2000 | A |
6080188 | Rowley et al. | Jun 2000 | A |
6112120 | Correas | Aug 2000 | A |
6112121 | Paul et al. | Aug 2000 | A |
6125302 | Kuzma | Sep 2000 | A |
6134478 | Spehr | Oct 2000 | A |
6161047 | King et al. | Oct 2000 | A |
6154678 | Lauro | Nov 2000 | A |
6162101 | Fischer et al. | Dec 2000 | A |
6164284 | Schulman et al. | Dec 2000 | A |
6167311 | Rezai | Dec 2000 | A |
6167314 | Fischer, Sr. et al. | Dec 2000 | A |
6175710 | Kamaji et al. | Jan 2001 | B1 |
6181969 | Gord | Jan 2001 | B1 |
6185452 | Schulman et al. | Feb 2001 | B1 |
6192278 | Werner et al. | Feb 2001 | B1 |
6198969 | Kuzma | Mar 2001 | B1 |
6208894 | Schulman et al. | Mar 2001 | B1 |
6224450 | Norton | May 2001 | B1 |
6271094 | Boyd et al. | Aug 2001 | B1 |
6295944 | Lovett | Oct 2001 | B1 |
6319021 | Billman | Nov 2001 | B1 |
6321126 | Kuzma | Nov 2001 | B1 |
6322559 | Daulton et al. | Nov 2001 | B1 |
6343233 | Werner et al. | Jan 2002 | B1 |
6364278 | Lin et al. | Apr 2002 | B1 |
6370434 | Zhang et al. | Apr 2002 | B1 |
6391985 | Goode et al. | May 2002 | B1 |
6397108 | Camps et al. | May 2002 | B1 |
6415168 | Putz | Jul 2002 | B1 |
6428336 | Akerfeldt | Aug 2002 | B1 |
6428368 | Hawkins et al. | Aug 2002 | B1 |
6430442 | Peters et al. | Aug 2002 | B1 |
6466824 | Struble | Oct 2002 | B1 |
6473654 | Chinn | Oct 2002 | B1 |
6498952 | Imani et al. | Dec 2002 | B2 |
6510347 | Borkan | Jan 2003 | B2 |
6516227 | Meadows et al. | Feb 2003 | B1 |
6556873 | Smits | Apr 2003 | B1 |
6564078 | Marino et al. | May 2003 | B1 |
6604283 | Kuzma | Aug 2003 | B1 |
6605094 | Mann et al. | Aug 2003 | B1 |
6609029 | Mann et al. | Aug 2003 | B1 |
6609032 | Woods et al. | Aug 2003 | B1 |
6654641 | Froberg | Nov 2003 | B1 |
6662035 | Sochor | Dec 2003 | B2 |
6663570 | Mott | Dec 2003 | B2 |
6671534 | Putz | Dec 2003 | B2 |
6671553 | Helland et al. | Dec 2003 | B1 |
6678564 | Ketterl et al. | Jan 2004 | B2 |
6725096 | Chinn et al. | Apr 2004 | B2 |
6741892 | Meadows et al. | May 2004 | B1 |
6757039 | Ma | Jun 2004 | B2 |
6757970 | Kuzma et al. | Jul 2004 | B1 |
6799991 | Williams et al. | Oct 2004 | B2 |
6805675 | Gardeski et al. | Oct 2004 | B1 |
6854994 | Stein et al. | Feb 2005 | B2 |
6878013 | Behan | Apr 2005 | B1 |
6895276 | Kast et al. | May 2005 | B2 |
6913478 | Lamrey | Jul 2005 | B2 |
6921295 | Sommer et al. | Jul 2005 | B2 |
6968235 | Belden et al. | Nov 2005 | B2 |
6980863 | van Venrooj et al. | Dec 2005 | B2 |
7027852 | Helland | Apr 2006 | B2 |
7047084 | Erickson et al. | May 2006 | B2 |
7058452 | Dahberg | Jun 2006 | B2 |
7069081 | Biggs et al. | Jun 2006 | B2 |
7083474 | Fleck et al. | Aug 2006 | B1 |
7108549 | Lyu et al. | Sep 2006 | B2 |
7110827 | Sage et al. | Sep 2006 | B2 |
7128600 | Osypka | Oct 2006 | B2 |
7155283 | Ries et al. | Dec 2006 | B2 |
7164951 | Ries et al. | Jan 2007 | B2 |
7168165 | Calzada et al. | Jan 2007 | B2 |
7191009 | Laske et al. | Mar 2007 | B2 |
7195523 | Naviaux | Mar 2007 | B2 |
7203548 | Whitehurst et al. | Apr 2007 | B2 |
7225034 | Ries et al. | May 2007 | B2 |
7231253 | Tidemand et al. | Jun 2007 | B2 |
7241180 | Rentas | Jul 2007 | B1 |
7242987 | Holleman et al. | Jul 2007 | B2 |
7244150 | Brase et al. | Jul 2007 | B1 |
7270568 | Osypka | Sep 2007 | B2 |
7283878 | Brostrom et al. | Oct 2007 | B2 |
7286882 | Cole | Oct 2007 | B2 |
7287995 | Stein et al. | Oct 2007 | B2 |
7292890 | Whitehurst et al. | Nov 2007 | B2 |
7396335 | Gardeski et al. | Jul 2008 | B2 |
7402083 | Kast et al. | Jul 2008 | B2 |
7422487 | Osypka | Sep 2008 | B2 |
7430958 | Wong | Oct 2008 | B2 |
7437193 | Parramon et al. | Oct 2008 | B2 |
7450997 | Pianca et al. | Nov 2008 | B1 |
7489971 | Franz | Feb 2009 | B1 |
7512446 | Honeck | Mar 2009 | B2 |
7516447 | Marvin et al. | Apr 2009 | B2 |
7526339 | Lahti et al. | Apr 2009 | B2 |
7539542 | Malinowski | May 2009 | B1 |
7548788 | Chinn et al. | Jun 2009 | B2 |
7554493 | Rahman | Jun 2009 | B1 |
7583999 | Bedenbaugh | Sep 2009 | B2 |
7585190 | Osypka | Sep 2009 | B2 |
7590451 | Tronnes et al. | Sep 2009 | B2 |
7650184 | Walter | Jan 2010 | B2 |
7668601 | Hegland et al. | Feb 2010 | B2 |
7672734 | Anderson et al. | Mar 2010 | B2 |
7736191 | Sochor | Jun 2010 | B1 |
7758384 | Alexander et al. | Jul 2010 | B2 |
7761165 | He et al. | Jul 2010 | B1 |
7761985 | Hegland et al. | Jul 2010 | B2 |
7783359 | Meadows | Aug 2010 | B2 |
7792590 | Pianca et al. | Sep 2010 | B1 |
7798864 | Barker et al. | Sep 2010 | B2 |
7803021 | Brase | Sep 2010 | B1 |
7809446 | Meadows | Oct 2010 | B2 |
7822477 | Rey et al. | Oct 2010 | B2 |
7822482 | Gerber | Oct 2010 | B2 |
7840188 | Kurokawa | Nov 2010 | B2 |
7848802 | Goetz | Dec 2010 | B2 |
7856707 | Cole | Dec 2010 | B2 |
7860570 | Whitehurst et al. | Dec 2010 | B2 |
7949395 | Kuzma | May 2011 | B2 |
7974705 | Zdeblick et al. | Jul 2011 | B2 |
7974706 | Moffitt et al. | Jul 2011 | B2 |
7979140 | Schulman | Jul 2011 | B2 |
8000808 | Hegland et al. | Aug 2011 | B2 |
8019440 | Kokones et al. | Sep 2011 | B2 |
8036755 | Franz | Oct 2011 | B2 |
8041309 | Kurokawa | Oct 2011 | B2 |
8046073 | Pianca | Oct 2011 | B1 |
8046074 | Barker | Oct 2011 | B2 |
8078280 | Sage | Dec 2011 | B2 |
8099177 | Dahlberg | Jan 2012 | B2 |
8100726 | Harlan et al. | Jan 2012 | B2 |
8140163 | Daglow et al. | Mar 2012 | B1 |
8167660 | Dilmaghanian et al. | May 2012 | B2 |
8175710 | He | May 2012 | B2 |
8190259 | Smith et al. | May 2012 | B1 |
8206180 | Kast et al. | Jun 2012 | B1 |
8224450 | Brase | Jul 2012 | B2 |
8225504 | Dye et al. | Jul 2012 | B2 |
8239042 | Chinn et al. | Aug 2012 | B2 |
8271094 | Moffitt et al. | Sep 2012 | B1 |
8295944 | Howard et al. | Oct 2012 | B2 |
8301255 | Barker | Oct 2012 | B2 |
8321025 | Bedenbaugh | Nov 2012 | B2 |
8342887 | Gleason et al. | Jan 2013 | B2 |
8359107 | Pianca et al. | Jan 2013 | B2 |
8364278 | Pianca et al. | Jan 2013 | B2 |
8391985 | McDonald | Mar 2013 | B2 |
8412330 | Kast et al. | Apr 2013 | B2 |
8527054 | North | Sep 2013 | B2 |
8583237 | Bedenbaugh | Nov 2013 | B2 |
8600507 | Brase et al. | Dec 2013 | B2 |
8682439 | DeRohan et al. | Mar 2014 | B2 |
8688235 | Pianca et al. | Apr 2014 | B1 |
8784143 | Edgell et al. | Jul 2014 | B2 |
8831742 | Pianca et al. | Sep 2014 | B2 |
8849396 | DeRohan et al. | Sep 2014 | B2 |
8849415 | Bedenbaugh | Sep 2014 | B2 |
8897876 | Sundaramurthy et al. | Nov 2014 | B2 |
8897891 | Romero | Nov 2014 | B2 |
8968331 | Sochor | Mar 2015 | B1 |
9101775 | Barker | Aug 2015 | B2 |
9149630 | Howard et al. | Oct 2015 | B2 |
9162048 | Romero et al. | Oct 2015 | B2 |
9234591 | Dilmaghanian et al. | Jan 2016 | B2 |
9270070 | Pianca | Feb 2016 | B2 |
9289596 | Leven | Mar 2016 | B2 |
9352147 | Nguyen-stella et al. | May 2016 | B2 |
9381348 | Romero et al. | Jul 2016 | B2 |
9403022 | Ries et al. | Aug 2016 | B2 |
9409032 | Brase et al. | Aug 2016 | B2 |
9440066 | Black | Sep 2016 | B2 |
9498618 | Stetson et al. | Nov 2016 | B2 |
9498620 | Romero et al. | Nov 2016 | B2 |
9504839 | Leven | Nov 2016 | B2 |
9604068 | Malinowski | Mar 2017 | B2 |
9656093 | Villarta et al. | May 2017 | B2 |
9770598 | Malinowski et al. | Sep 2017 | B2 |
9855413 | Vadlamudi et al. | Jan 2018 | B2 |
20010023368 | Black et al. | Sep 2001 | A1 |
20020143376 | Chinn et al. | Oct 2002 | A1 |
20020156513 | Borkan | Oct 2002 | A1 |
20020183817 | Van Venrooij et al. | Dec 2002 | A1 |
20030163171 | Kast et al. | Aug 2003 | A1 |
20040064164 | Ries et al. | Apr 2004 | A1 |
20040230268 | Huff et al. | Nov 2004 | A1 |
20040260373 | Ries et al. | Dec 2004 | A1 |
20050015130 | Gill | Jan 2005 | A1 |
20050027326 | Ries et al. | Feb 2005 | A1 |
20050027327 | Ries et al. | Feb 2005 | A1 |
20050038489 | Grill | Feb 2005 | A1 |
20050043770 | Hine et al. | Feb 2005 | A1 |
20050043771 | Sommer et al. | Feb 2005 | A1 |
20050137665 | Cole | Jun 2005 | A1 |
20050171587 | Daglow et al. | Aug 2005 | A1 |
20050186829 | Balsells | Aug 2005 | A1 |
20050272280 | Osypka | Dec 2005 | A1 |
20060015163 | Brown | Jan 2006 | A1 |
20060025841 | McIntyre | Feb 2006 | A1 |
20060030918 | Chinn | Feb 2006 | A1 |
20060167522 | Malinowski | Jul 2006 | A1 |
20060224208 | Naviaux | Oct 2006 | A1 |
20060247697 | Sharma et al. | Nov 2006 | A1 |
20060247749 | Colvin | Nov 2006 | A1 |
20060259106 | Arnholt et al. | Nov 2006 | A1 |
20070042648 | Balsells | Feb 2007 | A1 |
20070142889 | Whitehurst et al. | Jun 2007 | A1 |
20070150036 | Anderson | Jun 2007 | A1 |
20070161294 | Brase et al. | Jul 2007 | A1 |
20070168007 | Kuzma et al. | Jul 2007 | A1 |
20070203546 | Stone et al. | Aug 2007 | A1 |
20070219551 | Honour et al. | Sep 2007 | A1 |
20080077186 | Thompson et al. | Mar 2008 | A1 |
20080103580 | Gerber | May 2008 | A1 |
20080114230 | Addis | May 2008 | A1 |
20080139031 | Ries et al. | Jun 2008 | A1 |
20080177167 | Janzig et al. | Jul 2008 | A1 |
20080208277 | Janzig et al. | Aug 2008 | A1 |
20080208278 | Janzig et al. | Aug 2008 | A1 |
20080208279 | Janzig et al. | Aug 2008 | A1 |
20080215125 | Farah et al. | Sep 2008 | A1 |
20080255647 | Jensen et al. | Oct 2008 | A1 |
20080274651 | Boyd et al. | Nov 2008 | A1 |
20090054941 | Eggen et al. | Feb 2009 | A1 |
20090187222 | Barker | Jul 2009 | A1 |
20090204192 | Carlton et al. | Aug 2009 | A1 |
20090264943 | Barker | Oct 2009 | A1 |
20090276021 | Meadows et al. | Nov 2009 | A1 |
20090287191 | Ferren et al. | Nov 2009 | A1 |
20100029127 | Sjostedt | Feb 2010 | A1 |
20100030298 | Martens et al. | Feb 2010 | A1 |
20100036468 | Decre et al. | Feb 2010 | A1 |
20100057176 | Barker | Mar 2010 | A1 |
20100070012 | Chinn et al. | Mar 2010 | A1 |
20100076535 | Pianca et al. | Mar 2010 | A1 |
20100077606 | Black et al. | Apr 2010 | A1 |
20100082076 | Lee et al. | Apr 2010 | A1 |
20100094387 | Pianca et al. | Apr 2010 | A1 |
20100100152 | Martens et al. | Apr 2010 | A1 |
20100268298 | Moffift et al. | Oct 2010 | A1 |
20100269338 | Dye | Oct 2010 | A1 |
20100269339 | Dye et al. | Oct 2010 | A1 |
20100287770 | Dadd et al. | Nov 2010 | A1 |
20110004267 | Meadows | Jan 2011 | A1 |
20110005069 | Pianca | Jan 2011 | A1 |
20110022100 | Brase et al. | Jan 2011 | A1 |
20110047795 | Turner et al. | Mar 2011 | A1 |
20110056076 | Hegland et al. | Mar 2011 | A1 |
20110077699 | Swanson et al. | Mar 2011 | A1 |
20110078900 | Pianca et al. | Apr 2011 | A1 |
20110130803 | McDonald | Jun 2011 | A1 |
20110130816 | Howard et al. | Jun 2011 | A1 |
20110130817 | Chen | Jun 2011 | A1 |
20110130818 | Chen | Jun 2011 | A1 |
20110131808 | Gill | Jun 2011 | A1 |
20110184480 | Kast et al. | Jul 2011 | A1 |
20110238129 | Moffitt et al. | Sep 2011 | A1 |
20110245903 | Schulte et al. | Oct 2011 | A1 |
20110270330 | Janzig et al. | Nov 2011 | A1 |
20110301665 | Mercanzini et al. | Dec 2011 | A1 |
20110313500 | Barker et al. | Dec 2011 | A1 |
20120016378 | Pianca et al. | Jan 2012 | A1 |
20120046710 | DiGiore et al. | Feb 2012 | A1 |
20120053646 | Brase et al. | Mar 2012 | A1 |
20120071937 | Sundaramurthy et al. | Mar 2012 | A1 |
20120071949 | Pianca et al. | Mar 2012 | A1 |
20120165911 | Pianca | Jun 2012 | A1 |
20120185019 | Schramm et al. | Jul 2012 | A1 |
20120197375 | Pianca et al. | Aug 2012 | A1 |
20120203302 | Moffit et al. | Aug 2012 | A1 |
20120203316 | Moffitt et al. | Aug 2012 | A1 |
20120203320 | DiGiore et al. | Aug 2012 | A1 |
20120203321 | Moffitt et al. | Aug 2012 | A1 |
20120232603 | Sage | Sep 2012 | A1 |
20120253443 | Dilmaghanian et al. | Oct 2012 | A1 |
20120259386 | DeRohan et al. | Oct 2012 | A1 |
20120316615 | DiGiore et al. | Dec 2012 | A1 |
20130053864 | Geroy et al. | Feb 2013 | A1 |
20130098678 | Barker | Apr 2013 | A1 |
20130105071 | DiGiore et al. | May 2013 | A1 |
20130109254 | Klardie et al. | May 2013 | A1 |
20130116754 | Sharma et al. | May 2013 | A1 |
20130149031 | Changsrivong et al. | Jun 2013 | A1 |
20130197424 | Bedenbaugh | Aug 2013 | A1 |
20130197602 | Pianca et al. | Aug 2013 | A1 |
20130197603 | Eiger | Aug 2013 | A1 |
20130218154 | Carbunaru | Aug 2013 | A1 |
20130261684 | Howard | Oct 2013 | A1 |
20130288501 | Russell et al. | Oct 2013 | A1 |
20130304140 | Derohan et al. | Nov 2013 | A1 |
20130317587 | Barker | Nov 2013 | A1 |
20130325091 | Pianca et al. | Dec 2013 | A1 |
20140039587 | Romero | Feb 2014 | A1 |
20140088666 | Goetz et al. | Mar 2014 | A1 |
20140142671 | Moffitt et al. | May 2014 | A1 |
20140148885 | DeRohan et al. | May 2014 | A1 |
20140180375 | Pianca et al. | Jun 2014 | A1 |
20140353001 | Romero et al. | Dec 2014 | A1 |
20140358207 | Romero | Dec 2014 | A1 |
20140358208 | Howard et al. | Dec 2014 | A1 |
20140358209 | Romero et al. | Dec 2014 | A1 |
20140358210 | Howard et al. | Dec 2014 | A1 |
20150018915 | Leven | Jan 2015 | A1 |
20150021817 | Romero et al. | Jan 2015 | A1 |
20150025609 | Govea | Jan 2015 | A1 |
20150045864 | Howard | Feb 2015 | A1 |
20150066120 | Govea | Mar 2015 | A1 |
20150119965 | Govea | Apr 2015 | A1 |
20150151113 | Govea et al. | Jun 2015 | A1 |
20150209575 | Black | Jul 2015 | A1 |
20150360023 | Howard et al. | Dec 2015 | A1 |
20150374978 | Howard et al. | Dec 2015 | A1 |
20160059019 | Malinowski et al. | Mar 2016 | A1 |
20160129242 | Malinowski | May 2016 | A1 |
20160129265 | Malinowski | May 2016 | A1 |
20160158558 | Shanahan et al. | Jun 2016 | A1 |
20160206891 | Howard et al. | Jul 2016 | A1 |
20160228692 | Steinke et al. | Aug 2016 | A1 |
20160296745 | Govea et al. | Oct 2016 | A1 |
20160375238 | Leven et al. | Dec 2016 | A1 |
20170072187 | Howard et al. | Mar 2017 | A1 |
20170143978 | Barker | May 2017 | A1 |
20170203104 | Nageri et al. | Jul 2017 | A1 |
20170361108 | Leven | Dec 2017 | A1 |
20180008832 | Leven | Jan 2018 | A1 |
20180028820 | Nageri | Feb 2018 | A1 |
20180093098 | Nageri et al. | Apr 2018 | A1 |
20180214687 | Nageri et al. | Aug 2018 | A1 |
20180243570 | Malinowski et al. | Aug 2018 | A1 |
20180289968 | Lopez | Oct 2018 | A1 |
20180369596 | Funderburk | Dec 2018 | A1 |
20190030345 | Funderburk | Jan 2019 | A1 |
20190083793 | Nageri | Mar 2019 | A1 |
20190083794 | Nageri | Mar 2019 | A1 |
20190103696 | Conger | Apr 2019 | A1 |
Number | Date | Country |
---|---|---|
0580928 | Feb 1994 | EP |
0650694 | Jul 1998 | EP |
0832667 | Feb 2004 | EP |
1181947 | Jan 2006 | EP |
1625875 | Feb 2006 | EP |
2092952 | Aug 2009 | EP |
1997032628 | Sep 1997 | WO |
1999055411 | Feb 2000 | WO |
2000038574 | Jul 2000 | WO |
2001058520 | Aug 2001 | WO |
2002068042 | Sep 2002 | WO |
2004045707 | Jun 2004 | WO |
2008018067 | Feb 2008 | WO |
2008053789 | May 2008 | WO |
2008100841 | Aug 2008 | WO |
2009025816 | Feb 2009 | WO |
2009102536 | Aug 2009 | WO |
2009148939 | Dec 2009 | WO |
2013162775 | Oct 2013 | WO |
2014018092 | Jan 2014 | WO |
Number | Date | Country | |
---|---|---|---|
20180289968 A1 | Oct 2018 | US |
Number | Date | Country | |
---|---|---|---|
62483141 | Apr 2017 | US |